medical stocks
-
GSK gene therapy close to EU submission, CRISPR closes new cash, Takeda settles Actos (Morning Read)
Takeda has reached a settle over the cancer lawsuits connected to Actos diabetes treatment. Three big players came in on CRISPR Therapeutics’ round. And it looks like GlaxoSmithKline will be the first big pharma company to file for marketing approval for a gene therapy in to combat adenosine deaminase severe combined immune deficiency in Europe.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
PatientsLikeMe’s multiyear deal with AstraZeneca will impact global R&D
In an effort to tap patient communities for insights on drug development, AstraZeneca has inked […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Go West, young man: Sachin Jain leaving Merck and pharma for care delivery work
Sachin Jain, the Chief Medical Information and Innovation Officer at Merck, is leaving at the […]
-
Devices & Diagnostics, Health IT, Startups
Validic scoops up Pfizer, Everyday Health as clients for data aggregation platform
Validic, which developed an API to retrieve data from medical devices and wearables tracking health […]
-
Health IT, Hospitals, Startups
Xerox makes big push into telemedicine with HealthSpot strategic partnership
Xerox has made a strategic investment in telemedicine company HealthSpot, according to a company statement. […]
-
Would healthcare industry adopt your digital health tech? Connected Health program offers assessment
Three years ago Boehringer-Ingelheim set up a team called New Business Model and Healthcare Innovation […]